Medicine Grand Rounds: Aytpical fractures as a Potential Complication of Long Term Osteoporosis Therapy

When:
June 20, 2018 @ 8:00 am – 9:00 am
2018-06-20T08:00:00-07:00
2018-06-20T09:00:00-07:00
Where:
LK130
Li Ka Shing Building
291 Campus Drive, Palo Alto, CA 94305
USA
Cost:
Free
Contact:
Talia Ochoa
Medicine Grand Rounds: Aytpical fractures as a Potential Complication of Long Term Osteoporosis Therapy @ LK130 | Palo Alto | California | United States

Presenter: Deborah Sellmeyer, MD
Clinical Professor of Endocrinology, Gerontology, and Metabolism                                          Stanford University

Dr. Sellmeyer is an internationally recognized expert in Metabolic Bone Disease. She is a renowned clinician who joined the Stanford faculty in 2018 as a Professor of Medicine. She has been recognized for her clinical excellence with induction into the Miller Coulson Academy of Clinical Excellence while she was at Johns Hopkins. In addition to her clinical expertise, Dr. Sellmeyer maintains a research program that centers on the effect of nutrition and environmental factors on skeletal metabolism which she has investigated through both smaller CRC-based trials and large multi-center trials. Studies she has conducted have investigated the role of dietary sodium chloride, source of dietary protein (animal, vegetable, dairy, soy), role of dietary potassium and alkaline potassium salts, targeted thoracic exercises on kyphosis, whether structured exercise can prevent bone loss in premenopausal women treated for breast cancer, and studies validating nutritional assessment questionnaires. Her expertise as a clinical researcher has enabled development of a multi-disciplinary translational research team including basic scientists in the orthopedic department, junior faculty members with K grant funding, and basic scientists in the endocrine division to develop translational projects studying the effects of osteoporosis medications on basic elements of skeletal biology utilizing bone biopsies from treated individuals as well as clinical trials of novel therapies for rare bone disorders. Dr. Sellmeyer also is a esteemed educator, having received multiple teaching awards.